3M Company (MMM) Valuation

Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)

3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabili...

3M Company (MMM) currently trades at a P/E ratio of 28.35 (historical range: 8.72–82.11, median: 17.94), placing it at the 86th percentile — expensive relative to its history, P/S ratio of 3.37 (range: 1.45–3.81, 81th percentile — expensive relative to its history), EV/EBITDA of 20.07 (range: 15.83–20.64, 81th percentile).

Over the historical period (2021-09-14 to 2026-10-16), 3M Company's P/E ratio has expanded by 104% over the observed period (from an average of 14.0 to 28.5).

3M Company trades well above its own historical valuation range across most metrics.

Historical Valuation Metrics

MetricCurrentMedian%ileAssessment
P/E Ratio28.3517.9486thexpensive relative to its history
P/S Ratio3.372.5681thexpensive relative to its history
EV/EBITDA20.0719.0481thexpensive relative to its history
FCF Yield4.69%6.00%31thabove its historical average
Current Price: $165.00
Market Cap: $85.1B
Sector: Healthcare

3M Company (MMM) Valuation & P/E History

3M Company (MMM) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry currently trading at $165.00 with a market capitalization of $85.1 billion. This page provides historical valuation analysis for MMM based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 28.35 is above the historical median of 17.94, placing MMM at the 86th percentile of its valuation range. The P/S ratio of 3.37 compares to a median of 2.56.

MMM Valuation Metrics & Historical Range

The valuation table above shows 3M Company's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether MMM is currently trading above or below its typical valuation levels.

  • P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests MMM is expensively valued; below the median suggests it is cheap.
  • P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
  • EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for 3M Company.
  • FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.

Is MMM Overvalued or Undervalued?

3M Company trades well above its own historical valuation range across most metrics. The overall valuation percentile of 83 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive MMM is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.

However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full MMM analysis page for a complete picture.

Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.MMM trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Healthcare
More Surgical & Medical Instruments & Apparatus stocks
Cheaper alternatives
Similar fundamentals